BAYRY.PK: Summary for BAYER AKTIENGES ADS - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 8:17am EST - Canadian Markets open in 1 hour and 13 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

BAYER AKTIENGES ADS (BAYRY.PK)

On Feb 9: 66.50 USD 0.00 (0.00%)

MORE ON BAYRY.PK

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BAYER AKTIENGES ADS (Other OTC:BAYRY.PK) Delayed quote data

Last Trade:	66.50 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	66.50
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	95.00

Day's Range:	N/A - N/A
52wk Range:	42.65 - 81.60
Volume:	0
Avg Vol (3m):	56,204.8
Market Cap:	N/A
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	1.81 (2.72%)

1d 5d 3m 6m 1y 2y 5y max

Add BAYRY.PK to Portfolio

Download Data

HEADLINES

•	10 German Blue-Chips
	at Seeking Alpha (Wed, Jan 20)

•	Biotech Stocks: Novo Nordisk, Bayer and J&J lead downward trend
	at MarketWatch (Fri, Jan 15)

•	10 High Yielding German Stocks
	at Seeking Alpha (Tue, Dec 15)

•	Bayer Conference Call to discuss new clinical data presented during the Annual Meeting of ASH scheduled for 10:00 am ET today
	CCBN (Tue, Dec 8)

•	Biotech Stocks: Europe drug stocks rally; Cephalon slides
	at MarketWatch (Mon, Nov 23)

•	UK health unit rejects Bayer drug as too expensive
	at MarketWatch (Thu, Nov 19)

•	Bayer Earnings Call scheduled for 10:00 am ET today
	CCBN (Tue, Oct 27)

•	Buzzed Off At Bayer
	at Forbes.com (Fri, Oct 16)

•	Syngenta upgraded to outperform at Credit Suisse
	at MarketWatch (Mon, Oct 5)

•	Bayer downgraded to neutral from buy at UBS
	at MarketWatch (Wed, Sep 30)

•	Bayer, Onyx report progress on breast-cancer drug
	at MarketWatch (Wed, Sep 30)

•	Monsanto Backs French Biotech Firm
	at Forbes.com (Tue, Sep 1)

More Headlines for BAYRY.PK...

ANALYST

EPS Est (next year) (Dec-07) :	N/A
EPS Est (in 2 years) (Dec-08) :	6.03
Avg Rec (current)*:	1.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

No business summary available for BAYRY.PK.

Add to Portfolio

Email to a Friend

•